Company Filing History:
Years Active: 2020-2023
Title: Sam T Hwang: Innovator in Biopharmaceuticals
Introduction
Sam T Hwang is a notable inventor based in Brookfield, WI (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative polypeptides for therapeutic applications. With a total of 2 patents, Hwang's work is paving the way for advancements in the treatment of various medical conditions.
Latest Patents
Hwang's latest patents include the "Engineered CCL20 locked dimer polypeptide." This invention provides a CCL20 locked dimer polypeptide, pharmaceutical compositions thereof, and methods of using said dimer in the treatment of psoriasis and psoriatic arthritis. Another patent under his name also focuses on the same polypeptide, emphasizing its application in treating psoriasis, inflammatory disorders, and autoimmune diseases.
Career Highlights
Sam T Hwang is affiliated with the Medical College of Wisconsin, Inc., where he conducts his research and development work. His innovative approach to biopharmaceuticals has garnered attention in the scientific community, contributing to the advancement of therapeutic options for patients.
Collaborations
Hwang has collaborated with esteemed colleagues such as Brian Volkman and Anthony E Getschman. These partnerships have enhanced the scope and impact of his research, leading to significant advancements in the field.
Conclusion
Sam T Hwang is a distinguished inventor whose work in biopharmaceuticals is making a difference in the treatment of complex medical conditions. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.